Importance: Risk to airflow limitation and Chronic Obstructive Pulmonary Disease (COPD) is influenced by combinations of cigarette smoking and genetic susceptibility, yet it remains unclear whether gene-by-smoking interactions contribute to quantitative measures of lung function.
Objective: Determine whether smoking modifies the effect of a polygenic risk score's (PRS's) association with reduced lung function.
Design: United Kingdom (UK) Biobank prospective cohort study.
Setting: Population cohort.
Participants: UK citizens of European ancestry aged 40-69 years, with genetic and spirometry data passing quality control metrics.
Exposures: PRS, self-reported pack-years of smoking, ever- versus never-smoking status, and current- versus former-/never-smoking status.
Main Outcomes and Measures: Forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC). We tested for interactions with models including the main effects of PRS, different smoking variables, and their cross-product term(s). We also compared the effects of pack-years of smoking on FEV1/FVC for those in the highest versus lowest decile of predicted genetic risk for low lung function.
Results: We included 319,730 individuals (24,915 with moderate-to-severe COPD). The PRS and pack-years were significantly associated with lower FEV1/FVC, as was the interaction term (β [interaction] = -0.0028 [95% CI: -0.0029, -0.0026]; all p < 0.0001). A stepwise increment in estimated effect sizes for these interaction terms was observed per 10 pack-years of smoking exposure (all p < 0.0001). There was evidence of significant interaction between PRS with ever/never smoking status (β [interaction] = -0.0064 [95% CI: -0.0068, -0.0060]) and current/not-current smoking (β [interaction] = -0.0091 [95% CI: -0.0097, -0.0084]). For any given level of pack-years of smoking exposure, FEV1/FVC was significantly lower for individuals in the tenth compared to the first decile of genetic risk (p < 0.0001). For every 20 pack-years of smoking, those in the top compared to the bottom decile of genetic risk showed nearly a twofold reduction in FEV1/FVC.
Conclusions and Relevance: COPD is characterized by diminished lung function, and our analyses suggest there is substantial interaction between genome-wide PRS and smoking exposures. While smoking has negative effects on lung function across all genetic risk categories, effects of smoking are highest in those with higher predicted genetic risk.